Lillemäe Kadri, Järviö Johanna Annika, Silvasti-Lundell Marja Kaarina, Antinheimo Jussi Juha-Pekka, Hernesniemi Juha Antero, Niemi Tomi Tapio
Department of Perioperative, Intensive Care and Pain Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland; Department of Anesthesiology and Intensive Care Medicine, Helsinki University Hospital, Töölö Hospital, Helsinki, Finland.
Department of Perioperative, Intensive Care and Pain Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
World Neurosurg. 2017 Dec;108:491-497. doi: 10.1016/j.wneu.2017.09.007. Epub 2017 Sep 8.
We aimed to characterize the occurrence of postoperative hematoma (POH) after neurosurgery overall and according to procedure type and describe the prevalence of possible confounders.
Patient data between 2010 and 2012 at the Department of Neurosurgery in Helsinki University Hospital were retrospectively analyzed. A data search was performed according to the type of surgery including craniotomies; shunt procedures, spine surgery, and spinal cord stimulator implantation. We analyzed basic preoperative characteristics, as well as data about the initial intervention, perioperative period, revision operation and neurologic recovery (after craniotomy only).
The overall incidence of POH requiring reoperation was 0.6% (n = 56/8783) to 0.6% (n = 26/4726) after craniotomy, 0% (n = 0/928) after shunting procedure, 1.1% (n = 30/2870) after spine surgery, and 0% (n = 0/259) after implantation of a spinal cord stimulator. Craniotomy types with higher POH incidence were decompressive craniectomy (7.9%, n = 7/89), cranioplasty (3.6%, n = 4/112), bypass surgery (1.7%, n = 1/60), and epidural hematoma evacuation (1.6%, n = 1/64). After spinal surgery, POH was observed in 1.1% of cervical and 2.1% of thoracolumbar operations, whereas 46.7% were multilevel procedures. 64.3% of patients with POH and 84.6% of patients undergoing craniotomy had postoperative hypertension (systolic blood pressure >160 mm Hg or lower if indicated). Poor outcome (Glasgow Outcome Scale score 1-3), whereas death at 6 months after craniotomy was detected in 40.9% and 21.7%. respectively, of patients with POH who underwent craniotomy.
POH after neurosurgery was rare in this series but was associated with poor outcome. Identification of risk factors of bleeding, and avoiding them, if possible, might decrease the incidence of POH.
我们旨在全面描述神经外科手术后发生的术后血肿(POH)情况,并根据手术类型进行分析,同时描述可能的混杂因素的发生率。
对2010年至2012年赫尔辛基大学医院神经外科的患者数据进行回顾性分析。根据手术类型进行数据检索,包括开颅手术、分流手术、脊柱手术和脊髓刺激器植入术。我们分析了术前的基本特征,以及有关初始干预、围手术期、翻修手术和神经功能恢复(仅开颅手术后)的数据。
开颅手术后需要再次手术的POH总体发生率为0.6%(n = 56/8783)至0.6%(n = 26/4726),分流手术后为0%(n = 0/928),脊柱手术后为1.1%(n = 30/2870),脊髓刺激器植入后为0%(n = 0/259)。POH发生率较高的开颅手术类型包括减压性颅骨切除术(7.9%,n = 7/89)、颅骨成形术(3.6%,n = 4/112)、搭桥手术(1.7%,n = 1/60)和硬膜外血肿清除术(1.6%,n = 1/64)。脊柱手术后,颈椎手术中POH的发生率为1.1%,胸腰椎手术中为2.1%;其中46.7%为多节段手术。POH患者中有64.3%、开颅手术患者中有84.6%术后出现高血压(收缩压>160 mmHg,如有指征则更低)。结果不佳(格拉斯哥预后评分1 - 3分),开颅手术后6个月时,POH患者中分别有40.9%和21.7%死亡。
本系列研究中神经外科手术后的POH较为罕见,但与不良预后相关。识别出血的危险因素并尽可能避免这些因素,可能会降低POH的发生率。